Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.YJMCC.2004.11.001PMID 15623437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New perspectives on the key role of calcium in the progression of heart disease

  2004cited by this paper
• Inositol‐1,4,5‐trisphosphate‐dependent Ca2+ signalling in cat atrial excitation–contraction coupling and arrhythmias

  2004cited by this paper
• Internalization of neuropeptide Y Y1 and Y5 and of pancreatic polypeptide Y4 receptors is inhibited by lithium in preference to sodium and potassium ions.

  2004cited by this paper
• Neuropeptide Y Is an Essential In Vivo Developmental Regulator of Cardiac ICa,L

  2003cited by this paper
• Regulation of cardiac excitation–contraction coupling by action potential repolarization: role of the transient outward potassium current (Ito)

  2003cited by this paper
• Distribution of neuropeptide Y Y1 and Y2 receptors in the postmortem human heart.

  2003cited by this paper
• Neuropeptide Y increases 4‐aminopyridine‐sensitive transient outward potassium current in rat ventricular myocytes

  2002cited by this paper
• Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission.

  2002cited by this paper
• The signal transduction pathway causing the synergistic hypertrophic effects of neuropeptide Y and norepinephrine on primary cardiomyocyte.

  2001cited by this paper
• Neuropeptide Y Y2 receptor signalling mechanisms in the human glioblastoma cell line LN319.

  2001cited by this paper
• Potentiation of Ca2+ Release by cADP-Ribose in the Heart Is Mediated by Enhanced SR Ca2+ Uptake Into the Sarcoplasmic Reticulum

  2001cited by this paper
• Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes

  2001cited by this paper
• Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.

  2000cited by this paper
• The effects of low concentrations of caffeine on spontaneous Ca release in isolated rat ventricular myocytes.

  2000cited by this paper
• Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y1‐receptor in rat mesenteric small arteries

  2000cited by this paper
• Neuropeptide Y contributes to innervation-dependent increase in I(Ca, L) via ventricular Y2 receptors.

  1999cited by this paper
• Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C.

  1998cited by this paper
• Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis.

  1998cited by this paper
• Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors.

  1998cited by this paper
• Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes.

  1997cited by this paper
• Effects of [Ca2+]i, SR Ca2+ load, and rest on Ca2+ spark frequency in ventricular myocytes.

  1997cited by this paper
• Hemodynamic profile of neuropeptide Y in dogs: effect of ganglionic blockade.

  1997cited by this paper
• Effects of neuropeptide Y on L‐type calcium current in guinea‐pig ventricular myocytes

  1996cited by this paper
• Neuropeptide YY1 receptors-mediated increase in intracellular Ca2+ concentration via phospholipase C-dependent pathway in porcine aortic smooth muscle cells.

  1995cited by this paper
• Synergistic Interaction of Y1-Neuropeptide Y and -Adrenergic Receptors in the Regulation of Phospholipase C, Protein Kinase C, and Arachidonic Acid Production (*)

  1995cited by this paper
• Involvement of G‐protein αil subunits in activation of G‐protein gated inward rectifying K+ channels (GIRK1) by human NPY1 receptors

  1995cited by this paper
• Rapid desensitization of adrenaline‐ and neuropeptide Y‐stimulated Ca2+ mobilization in HEL‐cells

  1994cited by this paper
• Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes.

  1994cited by this paper
• Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle.

  1993cited by this paper
• Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms.

  1993cited by this paper
• Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activity. Structure-function studies.

  1992cited by this paper
• Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes.

  1991cited by this paper
• The effects of neuropeptide Y on myocardial contractility and coronary blood flow

  1991cited by this paper
• Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase

  1990cited by this paper
• Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles.

  1989cited by this paper
• Neuropeptide Y mobilizes intracellular Ca2+ and increases inositol phosphate production in human erythroleukemia cells.

  1989cited by this paper
• Neuropeptide Y‐induced intracellular Ca2+ increases in vascular smooth muscle cells

  1989cited by this paper
• Neuropeptide Y mobilizes Ca2+ and inhibits adenylate cyclase in human erythroleukemia cells.

  1988cited by this paper
• Nerve Fibers Containing Neuropeptide Y in the Cerebrovascular Bed: Immunocytochemistry, Radioimmunoassay, and Vasomotor Effects

  1987cited by this paper
• Effects of neuropeptide Y (NPY) on isolated guinea-pig heart.

  1987cited by this paper
• Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein.

  1987cited by this paper
• Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.

  1985cited by this paper
• High concentrations of a novel peptide, neuropeptide Y, in the innervation of mouse and rat heart.

  1984cited by this paper
• Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart.

  1983cited by this paper
• Neuropeptide Y: complete amino acid sequence of the brain peptide.

  1982cited by this paper

• Emotions & Heart:Exploring the Impact of Negative Emotions on Cardiovascular Health.

  2025cites this paper
• Ventricular Arrhythmias and Myocardial Infarction: Electrophysiological and Neuroimmune Mechanisms

  2025cites this paper
• Role of Neuropeptide B/W Signaling in Modulating Intracellular Calcium in Human Skin Fibroblasts.

  2025cites this paper
• Selective Receptor Modulation by Truncated Neuropeptide Y (3–36) Dissociates Vasoconstriction from Neuroprotection in Experimental Glaucoma

  2025cites this paper
• Neuropeptide Y Drives Ventricular Arrhythmogenesis in Chronic Ischemic Heart Failure via Calcium Mishandling.

  2025cites this paper
• Cardiac Sympathetic Innervation and Ventricular Arrhythmias in Structural Heart Disease: Current Peripheral Neuromodulation Therapies and Emerging Therapeutic Targets

  2025cites this paper
• Neuropeptide Y regulation of L-type Ca2+ channel activity is altered following chronic myocardial infarction

  2025influential citation
• The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies

  2024cites this paper
• Bayliss Starling Prize Lecture 2023: Neuropeptide‐Y being ‘unsympathetic’ to the broken hearted

  2024cites this paper
• Circulating Neuropeptide Y May Be a Biomarker for Diagnosing Atrial Fibrillation

  2023cites this paper
• Gβγ subunit signalling underlies neuropeptide Y‐stimulated vasoconstriction in rat mesenteric and coronary arteries

  2023cites this paper
• Autonomic control of ventricular function in health and disease: current state of the art

  2023cites this paper
• Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes

  2023cites this paper
• Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go

  2023cites this paper
• Response to the letter by Wang et al. "neuropeptide Y: A novel sympathetic neurotransmitter in arrhythmic promotion".

  2022cites this paper
• The Role of Neuro-Cardiac Junctions in Sympathetic Regulation of the Heart

  2021cites this paper
• Autonomic modulation of ventricular electrical activity: recent developments and clinical implications

  2021cites this paper
• Regulation of neuropeptide Y in body microenvironments and its potential application in therapies: a review

  2021cites this paper
• Protein kinase C mediates neuropeptide Y-induced reduction in inhibitory neurotransmission in the lateral habenula.

  2020cites this paper
• Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction

  2020cites this paper
• Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y.

  2020cites this paper
• The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade

  2020cites this paper
• Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers

  2020cites this paper
• NR4A nuclear receptors in cardiac remodeling and neurohormonal regulation.

  2019cites this paper
• OP-EHEA190901 1..12

  2019cites this paper
• Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure

  2019cites this paper
• The Effects of Neuropeptide Y Overexpression on the Mouse Model of Doxorubicin-Induced Cardiotoxicity

  2019cites this paper
• The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade

  2019cites this paper
• The Role of Neuropeptide Y in Cardiovascular Health and Disease

  2018cites this paper
• Nur77 protects against adverse cardiac remodelling by limiting neuropeptide Y signalling in the sympathoadrenal-cardiac axis

  2018cites this paper
• The gender-specific expression of neuropeptide Y and neuropeptide Y receptors in human atrial tissue during cardiopulmonary bypass surgery.

  2018cites this paper
• The role of neuropeptides in adverse myocardial remodeling and heart failure

  2017cites this paper
• NPY Impairs Cell Viability and Mitochondrial Membrane Potential Through Ca2+ and p38 Signaling Pathways in Neonatal Rat Cardiomyocytes

  2017cites this paper
• Neurocardiology: Cardiovascular Changes and Specific Brain Region Infarcts

  2017cites this paper
• Mechanisms of Brain Injury with On-Pump Cardiac Surgery

  2017cites this paper
• Putting together the clues of the everlasting neuro-cardiac liaison.

  2016cites this paper
• Caracterización de las acciones protectoras del ácido oleanolico en modelos experimentales de patologías con base inflamatoria

  2015cites this paper
• Neurological Regulation of the Circulation

  2014cites this paper
• Autonomic control of the heart: going beyond the classical neurotransmitters

  2014cites this paper
• Chapter 157 – PYY

  2013cites this paper
• Perivascular Innervation: A Multiplicity of Roles in Vasomotor Control and Myoendothelial Signaling

  2013cites this paper
• Cell-specific expression of calcineurin immunoreactivity within the rat basolateral amygdala complex and colocalization with the neuropeptide Y Y1 receptor.

  2012cites this paper
• Cardiovascular biology of the incretin system.

  2012cites this paper
• Osteoarthritic tissues modulate functional properties of sensory neurons associated with symptomatic OA pain

  2011cites this paper
• Mechanisms for the Regulation of Phospholipase C Gene Expression in Cardiac Hypertrophy

  2011cites this paper
• Neuropeptide Y and autonomic nervous system

  2011cites this paper
• Phospholipase C as a potential target for cardioprotection during oxidative stress.

  2010cites this paper
• Novel genetic variants contributing to left ventricular hypertrophy: the HyperGEN study

  2009cites this paper
• Sympathetic neurogenic Ca2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide Y

  2009cites this paper
• Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3‐L1 fibroblast cell line

  2009cites this paper
• Regulation of phospholipase C in cardiac hypertrophy

  2009cites this paper
• Variance of Peptidic Nerve Innervation in a Canine Model of Atrial Fibrillation Produced by Prolonged Atrial Pacing

  2008cites this paper
• Dissecting the NPY signaling cascade between cardiac sympathetic and parasympathetic nerves.

  2008cites this paper
• Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes.

  2008cites this paper
• Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells.

  2008cites this paper
• NPY and cardiac diseases.

  2007cites this paper
• Phospholipase Cβ3 is distributed in both somatodendritic and axonal compartments and localized around perisynapse and smooth endoplasmic reticulum in mouse Purkinje cell subsets

  2007cites this paper
• TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation.

  2007cites this paper
• Phospholipid-mediated signaling systems as novel targets for treatment of heart disease.

  2007cites this paper
• Neuropeptide tyrosine and pain.

  2007cites this paper
• Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells

  2007cites this paper
• Phospholipid-mediated signaling in diseased myocardium

  2006cites this paper
• Human NPY gene variants in cardiovascular and metabolic diseases.

  2006cites this paper
• Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice.

  2006cites this paper
• Modulation of Contractile Function through Neuropeptide Y Receptors during Development of Cardiomyocyte Hypertrophy

  2006cites this paper
• Mechanisms of [ Ca 2 ] i Transient Decrease in Cardiomyopathy of db / db Type 2 Diabetic Mice

  2006cites this paper